UroGenesys Inc., of Santa Monica, Calif., named Aya Jakobovits senior vice president, technology and corporate development, and added Paul Kanan as vice president of operations and chief financial officer

and David Westaway as senior vice president and general manager, oncology...EntreMed Inc., of Rockville, Md., appointed Edward Gubish president and chief operating officer and Neil Campbell vice president of corporate development

Millipore Corp., of Bedford, Mass., elected Francis Lunger president and chief operating officer...Paratek Pharmaceuticals Inc., of Boston, appointed Ken Tanaka vice president of research and development and Dennis Molnar executive director of corporate development

Aradigm Corp., of Hayward, Calif., appointed Stan Benson and Igor Gonda to its board...emerGen Inc., of Salt Lake City, added Jeffrey Williams as vice president, corporate development and strategy...InforMax Inc., of Bethesda, Md., named Patrick Blake vice president and managing director of Europe, Middle East and Africa operations

AltaRex Corp., of Waltham, Mass., appointed William Darrow and Robert Uhl to its board...Robert Jones vice president, platform products research and development...and Carolyn Martin vice president, field operations of the Americas

Ergo Science Corp., of Boston, elected Warren Huff and Charles Finelli to its board...FeRx Inc., of San Diego, added Richard Keatinge as vice president of corporate development and Kenneth Norton as senior director of pharmaceutical development...Also, it named Todd Myers chief financial officer and promoted Scott Rudge to vice president of operations and site director of its Colorado laboratories

Corvas International Inc., of San Diego, appointed Stephen Keane vice president, corporate development...ImmunoGen Inc., of Cambridge, Mass., appointed Gregg Beloff vice president and chief financial officer

Avidex Ltd., of Oxford, UK, appointed Peter Doyle and Alan Rosenthal nonexecutive directors...and Premchandran Ramiya director of process research and development

RxKinetix Inc., of Louisville, Colo., named Kenneth Lynn senior vice president of corporate development and legal affairs

Gill has been president and CEO of Genome Therapeutics Corp., of Waltham, Mass., and senior vice president and general manager of BTG International Inc., of Philadelphia...Wolfram Sterry, professor and chairman, Department of Dermatology, Chariti University Hospital, Humboldt University in Berlin...and Jerry Weisbach, former president of the Parke Davis Research Division, Warner-Lambert Co

Dragon Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Rita Jervis vice president, corporate development...plc, of Dublin, Ireland, named Lars Ekman president, research and development, Elan Pharmaceuticals...and Motohiro Ueda president & representative director, Elan Pharma K.K., Japan

ExonHit Therapeutics SA, of Paris, appointed Pierre Corvol and Dominique Stehelin to its scientific advisory board...He will continue to serve as controller and chief accounting officer...ICOS Corp., of Bothell, Wash., appointed Michael Stein vice president and chief financial officer

MedImmune Inc., of Gaithersburg, Md., promoted James Young to president, research and development, and Michael Richman to senior vice president, corporate development and administration

Kosan Biosciences Inc., of Hayward, Calif., added Robert Johnson to its senior executive management team and also named him vice president, medical affairs and corporate development...Paratek Pharmaceuticals Inc., of Boston, appointed Beverly Armstrong vice president and chief financial officer

and Scott Rollins to vice president, drug development and project management...Howson is the former senior vice president and director, worldwide business development, at SmithKline Beecham

Axys Pharmaceuticals Inc., of South San Francisco, named David Riggs senior vice president and chief financial officer...Genomics One Corp., of Laval, Quebec, appointed Michel Cousineau director of business development and marketing...MGI Pharma Inc., of Minneapolis, named Michael Cullen vice president, clinical affairs, and chief medical officer

Sequenom Inc., of San Diego, appointed Rick Episcopo senior vice president of commercial operations and William Burton vice president of corporate development

Coley Pharmaceutical Group, of Wellesley, Mass., named Robert Forrester senior vice president of finance and development, Yves Fouron vice president of corporate development, and Barbara Deptula vice president of commercial development

InterMune Pharmaceuticals Inc., of Burlingame, Calif., named John Wulf senior vice president of corporate development, and Karen Starko senior director of clinical research...Russell Granzow vice president, marketing, sales and business development...and Scott Rakestraw executive director of therapeutics business development